Beta Bionics, Inc. (BBNX)
Nasdaq: BBNX · Surgical & Medical Instruments & Apparatus · Irvine, CA · filing with the SEC since 2016
Who runs Beta Bionics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Saint Sean
President & CEO. First filing Jan 2025, latest Sep 4, 2026, 7 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
11 people on the record since 2025
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Feider Stephen | Chief Financial Officer | Jan 2025 | Nov 12, 2026 | 11 · $1.2M |
| Hopman Mark | Chief Commercial Officer | Jan 2025 | Nov 4, 2026 | 16 · $2.3M |
| Mensinger Mike | Chief Product Officer | Jan 2025 | Oct 29, 2026 | 9 · $600,000 |
| Saint Sean | President & CEO | Jan 2025 | Sep 4, 2026 | 5 · $800,000 |
| Russell Steven Jon | Chief Medical Officer | Jan 2025 | Sep 3, 2026 | 4 · $200,000 |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Jones Christy | director | Jan 2025 | Sep 23, 2026 | 4 · $200,000 |
| Carney Sean | director | Jan 2025 | May 26, 2026 | none |
| Dearen Danny L. | director | Jan 2025 | May 26, 2026 | none |
| Lezack Adam | director | Jan 2025 | May 26, 2026 | 4 · $100,000 |
| Michel Gerard J | director | Mar 2025 | May 26, 2026 | none |
| Palasis Maria | director | Jan 2025 | May 26, 2026 | 2 · $0.00 |
Earlier names on the record1, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.